8-K: Oscar Health Reaffirms 2026 Guidance at Conference
Regulation FD Disclosure
Oscar Health will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 8, 2026, to provide a business update and reaffirm its full-year 2026 guidance.
Summary
- Oscar Health, Inc. announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026.
- The company plans to provide a business update during a fireside chat.
- Oscar Health will reaffirm its previously issued full-year 2026 guidance, which was originally provided in its financial results press release dated February 10, 2026.
- A live audio webcast of the event will be available on the Investor Relations page of the company's website, with a replay accessible for approximately 90 days.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it confirms existing guidance and provides a platform for updates, but does not introduce new financial information or significant strategic shifts.
Positives
- Reaffirmation of full-year 2026 guidance suggests management confidence in meeting financial targets.
- Participation in a significant industry conference like the Goldman Sachs Global Healthcare Conference provides visibility and a platform to communicate business updates.
Risks
- Forward-looking statements are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond the company's control.
- Actual results could differ materially from those indicated in forward-looking statements due to factors detailed in the company's Form 10-K for the year ended December 31, 2025, and other SEC filings, including the Form 10-Q for the quarter ended March 31, 2026.
Future Outlook
The company plans to reaffirm its full-year 2026 guidance, previously provided on February 10, 2026. Specific details of the guidance are not reiterated in this filing, but the reaffirmation suggests continued confidence in achieving previously stated financial expectations.
Management Comments
- The company plans to provide a business update and reaffirm its full year 2026 guidance.
Industry Context
StockSavvy.ai notes that reaffirming guidance at a major healthcare conference signals management's conviction in its strategic direction and financial performance amidst a dynamic healthcare market.
Stakeholder Impact
- Shareholders: Reaffirmation of guidance may provide confidence in the company's financial outlook.
- Investors: Access to business updates and guidance reaffirmation via webcast and replay.
- Analysts: Opportunity to assess company performance and outlook at a key industry event.
Next Steps
- Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026.
- Provide a business update during the fireside chat.
- Reaffirm full-year 2026 guidance.
- Make a live audio webcast available on the Investor Relations page.
- Provide a replay of the webcast for approximately 90 days.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Year ended December 31, 2025 (referenced for Risk Factors in Form 10-K) |
| 2026-02-10 | Date of financial results press release providing initial full-year 2026 guidance |
| 2026-03-31 | Quarterly period ended March 31, 2026 (referenced for Form 10-Q filing) |
| 2026-06-08 | Date of report (earliest event reported) and date of participation in Goldman Sachs 47th Annual Global Healthcare Conference |
Keywords
Oscar Health, 8-K Filing, Guidance Reaffirmation, Healthcare Conference, Investor Relations, Financial Update, SEC Filing, Goldman Sachs
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.